RE:RE: RE: final approvalWith 800 million people in the EU, 23 million in Austraiia, 30 million in Canada, 175 million in Brazil and only 300 million people in the USA, it is no wonder Verisante chose to obtain licencing outside of the USA first. FDA approval is important but still small potatoes in the larger picture.